Of note, the TUBB4A gene was amplified in neuroendocrine prostate cancers, reaching 12–15% cases and in castration-resistant prostate cancers, reaching 8.57% (Fig. S1D). The gene discussed is TUBB4A; the disease is prostate carcinoma.